Name: ONCY Income Statement - Oncolytics Biotech Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ONCY - Oncolytics Biotech Inc.

USD | NASDAQ | Healthcare

ONCY Income Statement - Oncolytics Biotech Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q1 FY 25
Revenues
Revenues	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses
Research & Development	4.6	2.8
Selling General & Administrative	-	-
Selling & Marketing	-	-
General & Administrative	4.7	2.2
Depreciation & Amortization	0.0	0.0
Amortization of Intangibles	-	-
Other Operating Expenses	-	-
Total Operating Expenses	9.3	5.0
Operating Income
Operating Income	(9.3)	(5.0)
Non-Operating
Interest Income	0.0	0.1
Interest Expense	-	-
Income From Equity Investments	-	-
Other Non-Operating Income	0.0	0.3
Pre-Tax Income
Tax & Net
Income Tax Expense	-	-
Net Income From Continuing Ops	(9.2)	(4.7)
Net Income From Discontinued Ops	-	-
Net Income	(9.2)	(4.7)
Net Income Attributable To Parent
Per Share
EPS Basic	(0.08)	(0.06)
EPS Diluted	(0.08)	(0.06)
Shares Basic	112.3	84.6
Shares Diluted	112.3	84.6
Supplementary Data
EBITDA	(9.3)	(5.0)
EBIT	(9.3)	(5.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	FY2025	FY2024
Revenues
Revenues	-	-
Cost of Revenue	-	-
Gross Profit	-	-
Operating Expenses
Research & Development	13.3	15.4
Selling General & Administrative	-	-
Selling & Marketing	-	-
General & Administrative	15.4	10.1
Depreciation & Amortization	0.1	0.1
Amortization of Intangibles	-	-
Other Operating Expenses	-	-
Total Operating Expenses	28.7	25.5
Operating Income
Operating Income	(28.7)	(25.5)
Non-Operating
Interest Income	0.4	1.0
Interest Expense	-	-
Income From Equity Investments	-	-
Other Non-Operating Income	0.0	2.8
Pre-Tax Income
Tax & Net
Income Tax Expense	0.1	0.1
Net Income From Continuing Ops	(28.8)	(22.8)
Net Income From Discontinued Ops	-	-
Net Income	(28.8)	(22.8)
Net Income Attributable To Parent
Per Share
EPS Basic	(0.30)	(0.30)
EPS Diluted	(0.30)	(0.30)
Shares Basic	95.9	76.5
Shares Diluted	95.9	76.5
Supplementary Data
EBITDA	(28.7)	(25.5)
EBIT	(28.7)	(25.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)